The epitranscriptome: Tools to study, manipulate, and exploit RNA modifications

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

OriginalsprogEngelsk
TidsskriftCardiovascular Research
Vol/bind115
Udgave nummer13
Sider (fra-til)e133-e135
ISSN0008-6363
DOI
StatusUdgivet - 1 nov. 2019

Bibliografisk note

Funding Information:
Dr Nossent is funded by a Lise Meitner Grant from the Austrian Science Fund FWF (M2578-B30).

Funding Information:
Biography: Anne Yaël Nossent after completing her postdoc at the University of Copenhagen and the University of Southern Denmark, Dr Nossent initiated an independent research line on the role of microRNAs in neovascularisation at the Leiden University Medical Center in Netherlands. She was awarded a personal Veni grant by Netherlands Organization for Scientific Research to support this line of research. In her Veni project, she demonstrated a role for the 14q32 miRNAs in post-ischemic neovascularization. Dr Nossent and colleagues also demonstrated positive effects of 14q32 miRNA inhibition on atherosclerosis and restenosis. Besides 54 miRNAs however, the 14q32 locus also encodes 3 lncRNA and 41 snoRNAs. Dr Nossent was recently awarded grants by Netherlands Heart Foundation and the Rembrandt Institute for Cardiovascular Sciences to support further research on the role of these lncRNAs and snoRNAs in cardiovascular disease. In September 2017, Dr Nossent moved to Vienna, Austria, where she continues her research on noncoding RNAs, supported by a Lise Meitner Grant from the Austrian Science Fund FWF. She now holds a dual affiliation with both the Medical University of Vienna and the Leiden University Medical Center.

ID: 395076249